bromopyruvate has been researched along with Cancer of Colon in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abbaszadeh, H; Alboghobeish, S; Mahdavinia, M; Pipelzadeh, MH; Teimoori, A; Valizadeh, A; Zeidooni, L | 1 |
| Kustrzeba-Wójcicka, I; Szczuka, I; Terlecki, G; Wiśniewski, J | 1 |
| Jiang, C; Lan, Y; Liu, H; Liu, Z; Sun, X; Sun, Y; Wang, X; Zhao, S; Zou, X | 1 |
| Futagi, Y; Ideno, M; Iseki, K; Kobayashi, M; Narumi, K; Sasaki, S | 1 |
| Hernlund, E; Ihrlund, LS; Khan, O; Shoshan, MC | 1 |
| Cuezva, JM; Sánchez-Aragó, M | 1 |
| Buxhoeveden, M; Desbordes, C; Gengel, N; Kleinschmit, J; Lea, MA; Qureshi, MS | 1 |
| Fu, XL; Liang, HJ; Peng, QP; Zhong, DP; Zhou, JM; Zhou, Q | 1 |
8 other study(ies) available for bromopyruvate and Cancer of Colon
| Article | Year |
|---|---|
3-Bromopyruvate potentiates TRAIL-induced apoptosis in human colon cancer cells through a reactive oxygen species- and caspase-dependent mitochondrial pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspases; Colonic Neoplasms; Cytochromes c; Down-Regulation; Drug Synergism; Enzyme Activation; HEK293 Cells; HT29 Cells; Humans; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Reactive Oxygen Species; Survivin; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2019 |
The effect of 3-bromopyruvate on the properties of cathepsin B in the aspect of metastatic potential of colon cancer cells.
Topics: Caco-2 Cells; Cathepsin B; Colonic Neoplasms; Humans; Pyruvates | 2020 |
Mechanisms underlying 3-bromopyruvate-induced cell death in colon cancer.
Topics: Animals; Autophagy; Cell Line, Tumor; Colonic Neoplasms; Energy Metabolism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pyruvates; Xenograft Model Antitumor Assays | 2015 |
Influence of high glucose state on bromopyruvate-induced cytotoxity by human colon cancer cell lines.
Topics: Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Down-Regulation; Glucose; Humans; Lactic Acid; Pyruvates | 2016 |
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colonic Neoplasms; Deoxyglucose; Drug Synergism; Energy Metabolism; Glucose; Humans; Mitochondria; Organoplatinum Compounds; Oxaliplatin; Platinum Compounds; Pyruvates; Tumor Suppressor Protein p53 | 2008 |
The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil.
Topics: Adenosine Triphosphate; Blotting, Western; Cell Death; Colonic Neoplasms; Energy Metabolism; Fluorouracil; Glutamine; HCT116 Cells; Humans; Iodoacetates; Pyruvates; Remission Induction; Signal Transduction | 2011 |
Regulation of the proliferation of colon cancer cells by compounds that affect glycolysis, including 3-bromopyruvate, 2-deoxyglucose and biguanides.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biguanides; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxyglucose; Glycolysis; HT29 Cells; Humans; Pyruvates | 2013 |
[Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof].
Topics: Antineoplastic Agents; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Gene Expression; HCT116 Cells; Hexokinase; Humans; Membrane Potential, Mitochondrial; Organoplatinum Compounds; Oxaliplatin; Pyruvates; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |